"Energy was the third worst performing sector in 2024," BTIG analyst Jonathan Krinsky wrote in a research note this week. He added that it was the only sector in the red for the prior two years, ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Carisma Therapeutics, Inc. (NASDAQ:CARM – Get Free Report) has earned an average recommendation of “Hold” from the seven ...

In a report released today, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

Frontline plc (NYSE:FRO) is a company engaged in seaborne transportation of crude oil and refined products. The company owns ...

BTIG raised the firm’s price target on Chefs’ Warehouse (CHEF) to $58 from $50 and keeps a Buy rating on the shares. The firm believes ...

Fintel reports that on January 7, 2025, BTIG initiated coverage of Hims & Hers Health (NYSE:HIMS) with a Buy recommendation.

BTIG Research has recently reduced Fiverr International Ltd (FVRR) stock to Neutral rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 2, 2024, UBS had reduced the stock ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

BTIG maintains a “Buy” rating for Carvana Co. (NYSE:CVNA) with a stock price of $185.5. Carvana amends its agreement with ...

Carvana (CVNA) shares remain under pressure on the heels of a scathing short-seller report despite Wall Street analysts ...

The report centers on Carvana’s practice of loan sales as well as the business relationship between CEO Ernie Garcia III and ...